Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 186,300
-1,800 (-0.96%)
At close: Sep 7, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 44.71 trillion as of September 4, 2026. Its market cap has increased by 20.10% in one year.
Market Cap
44.71T
Enterprise Value
47.47T
Revenue
4.90T
Ranking
n/a
PE Ratio
27.24
Stock Price
186,300.00
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 44.71T, an increase of 42,973.57%. That is a compound annual growth rate of 39.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 44.71T | 12.90% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 66.91T |
| ALTEOGEN | 20.09T |
| Samsung Epis Holdings | 8.84T |
| SK Biopharmaceuticals | 6.78T |
| HLB Co., Ltd. | 4.49T |
| ABL Bio | 4.00T |
| Peptron | 3.67T |
| LigaChem Biosciences | 3.39T |